Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Marked and persistent eosinophilia in the absence of clinical manifestations.
Chen YY, Khoury P, Ware JM, Holland-Thomas NC, Stoddard JL, Gurprasad S, Waldner AJ, Klion AD. Chen YY, et al. Among authors: ware jm. J Allergy Clin Immunol. 2014 Apr;133(4):1195-202. doi: 10.1016/j.jaci.2013.06.037. Epub 2013 Aug 26. J Allergy Clin Immunol. 2014. PMID: 23987798 Free PMC article.
Hypereosinophilia in Children and Adults: A Retrospective Comparison.
Williams KW, Ware J, Abiodun A, Holland-Thomas NC, Khoury P, Klion AD. Williams KW, et al. J Allergy Clin Immunol Pract. 2016 Sep-Oct;4(5):941-947.e1. doi: 10.1016/j.jaip.2016.03.020. Epub 2016 Apr 27. J Allergy Clin Immunol Pract. 2016. PMID: 27130711 Free PMC article.
Dexpramipexole as an oral steroid-sparing agent in hypereosinophilic syndromes.
Panch SR, Bozik ME, Brown T, Makiya M, Prussin C, Archibald DG, Hebrank GT, Sullivan M, Sun X, Wetzler L, Ware J, Fay MP, Dunbar CE, Dworetzky SI, Khoury P, Maric I, Klion AD. Panch SR, et al. Blood. 2018 Aug 2;132(5):501-509. doi: 10.1182/blood-2018-02-835330. Epub 2018 May 8. Blood. 2018. PMID: 29739754 Free PMC article.
Benralizumab for PDGFRA-Negative Hypereosinophilic Syndrome.
Kuang FL, Legrand F, Makiya M, Ware J, Wetzler L, Brown T, Magee T, Piligian B, Yoon P, Ellis JH, Sun X, Panch SR, Powers A, Alao H, Kumar S, Quezado M, Yan L, Lee N, Kolbeck R, Newbold P, Goldman M, Fay MP, Khoury P, Maric I, Klion AD. Kuang FL, et al. N Engl J Med. 2019 Apr 4;380(14):1336-1346. doi: 10.1056/NEJMoa1812185. N Engl J Med. 2019. PMID: 30943337 Free PMC article. Clinical Trial.
Mechanisms of glucocorticoid resistance in hypereosinophilic syndromes.
Stokes K, Yoon P, Makiya M, Gebreegziabher M, Holland-Thomas N, Ware J, Wetzler L, Khoury P, Klion AD. Stokes K, et al. Clin Exp Allergy. 2019 Dec;49(12):1598-1604. doi: 10.1111/cea.13509. Epub 2019 Oct 27. Clin Exp Allergy. 2019. PMID: 31657082 Free PMC article. Clinical Trial.
A Randomized, Placebo-controlled, Double-blind Pilot Study of Single-dose Humanized Anti-IL5 Antibody (Reslizumab) for the Reduction of Eosinophilia Following Diethylcarbamazine Treatment of Loa loa Infection.
Legrand F, Herrick J, Makiya M, Ramanathan R, Thompson R, Rampertaap S, Stoddard J, Ware J, Fay MP, Holland-Thomas N, Nutman TB, Klion AD. Legrand F, et al. Clin Infect Dis. 2021 Oct 5;73(7):e1624-e1631. doi: 10.1093/cid/ciaa1365. Clin Infect Dis. 2021. PMID: 32910141 Free PMC article. Clinical Trial.
An International, Retrospective Study of Off-Label Biologic Use in the Treatment of Hypereosinophilic Syndromes.
Chen MM, Roufosse F, Wang SA, Verstovsek S, Durrani SR, Rothenberg ME, Pongdee T, Butterfield J, Lax T, Wechsler ME, Stein ML, Ogbogu PU, Kahwash BM, Mathur SK, Simon D, Akuthota P, Holland N, Wetzler L, Ware JM, Guo C, Fay MP, Khoury P, Klion AD, Bochner BS. Chen MM, et al. Among authors: ware jm. J Allergy Clin Immunol Pract. 2022 May;10(5):1217-1228.e3. doi: 10.1016/j.jaip.2022.02.006. Epub 2022 Feb 15. J Allergy Clin Immunol Pract. 2022. PMID: 35181548 Free PMC article.
29 results